Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × spartalizumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Solid Tumors 2 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1

Interventions

Fluorouracil 14 Oxaliplatin 12 Nivolumab 11 Leucovorin 11 Capecitabine 9 Paclitaxel 8 pembrolizumab 7 Radiation 5 Irinotecan 5 durvalumab 4 Trastuzumab 4 Taxes 4 Specimen Handling 4 Radiotherapy 4 Cisplatin 4 Carboplatin 4 Biopsy 4 dehydroftorafur 3 Endoscopy 3 Drug Therapy 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 tremelimumab 2 tislelizumab 2 Ramucirumab 2 Magnetic Resonance Spectroscopy 2 Folfox protocol 2 zolbetuximab 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡